A double-blind comparative study of the tolerance of sodium and meglumine ioxaglate (Hexabrix) with meglumine iothalamate (Conray) in ascending phlebography of the leg.
D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007463:Iodobenzoates / Q000009:adverse effects*; D007482:Iothalamate Meglumine / Q000009:adverse effects*; D007485:Ioxaglic Acid; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D010690:Phlebography; D012964:Sodium / Q000009:adverse effects*; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; C001694:meglumine ioxithalamate; D012964:Sodium; D007482:Iothalamate Meglumine; D007485:Ioxaglic Acid